Christoph Lange Selected Research

Christoph Lange Research Topics

Disease

77	Tuberculosis (Tuberculoses) 05/2024 - 11/2006
23	Infections 01/2023 - 03/2009
22	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 10/2023 - 12/2007
21	Asthma (Bronchial Asthma) 01/2023 - 12/2002
19	Chronic Obstructive Pulmonary Disease (COPD) 02/2023 - 08/2004
15	Extensively Drug-Resistant Tuberculosis 03/2024 - 12/2007
9	Pulmonary Tuberculosis 02/2024 - 11/2006
8	Latent Infection 10/2023 - 10/2012
7	COVID-19 11/2022 - 10/2020
5	Lung Diseases (Lung Disease) 01/2022 - 06/2009
4	Communicable Diseases (Infectious Diseases) 02/2024 - 08/2014
4	Pulmonary Aspergillosis 02/2024 - 01/2016
4	HIV Infections (HIV Infection) 11/2022 - 01/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2005
4	Neoplasms (Cancer) 07/2021 - 12/2010
3	Emphysema 02/2023 - 08/2011
3	Coinfection 01/2023 - 02/2013
3	Hypersensitivity (Allergy) 01/2023 - 02/2004
3	Respiratory Insufficiency (Respiratory Failure) 11/2022 - 01/2020
3	Persistent Infection 06/2009 - 01/2003
2	Sarcoidosis (Schaumann Disease) 02/2024 - 10/2009
2	Inflammation (Inflammations) 02/2024 - 02/2011
2	Latent Tuberculosis 07/2023 - 11/2022
2	Human Influenza (Influenza) 11/2022 - 10/2020
2	Respiratory Hypersensitivity 12/2019 - 11/2007
2	Heart Failure 01/2018 - 04/2009
2	Virus Diseases (Viral Diseases) 10/2015 - 01/2003
2	Schizophrenia (Dementia Praecox) 07/2015 - 06/2012
2	Rheumatoid Arthritis 11/2014 - 10/2013
2	Drug-Related Side Effects and Adverse Reactions 08/2014 - 07/2014
2	Obesity 10/2009 - 04/2006
1	Necrosis 04/2024
1	Pneumonia (Pneumonitis) 02/2024
1	Fibrosis (Cirrhosis) 02/2024

Drug/Important Bio-Agent (IBA)

17	InterferonsIBA 11/2022 - 10/2009
16	Rifampin (Rifampicin)FDA LinkGeneric 03/2024 - 01/2019
15	Tuberculin (PPD)IBA 02/2024 - 01/2008
13	bedaquiline (R207910)IBA 03/2024 - 04/2015
11	Biomarkers (Surrogate Marker)IBA 05/2024 - 08/2011
11	Proteins (Proteins, Gene)FDA Link 02/2023 - 03/2009
10	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 11/2003
10	VaccinesIBA 10/2023 - 10/2013
8	Linezolid (Zyvox)FDA Link 03/2024 - 10/2009
8	AntigensIBA 01/2017 - 08/2004
7	FluoroquinolonesIBA 03/2024 - 12/2007
7	EnzymesIBA 01/2018 - 11/2006
6	CytokinesIBA 02/2024 - 01/2014
6	Isoniazid (Ftivazide)FDA LinkGeneric 07/2023 - 10/2017
6	Bronchodilator Agents (Bronchodilators)IBA 02/2021 - 08/2003
5	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 12/2007
5	AcidsIBA 01/2020 - 11/2006
5	GoldIBA 01/2020 - 01/2008
5	Interleukin-2 (IL2)IBA 01/2017 - 07/2010
4	AntibodiesIBA 02/2024 - 07/2021
4	Messenger RNA (mRNA)IBA 01/2023 - 10/2009
4	Immunoglobulin E (IgE)IBA 01/2023 - 08/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2024 - 07/2005
3	Immunoglobulin G (IgG)IBA 02/2024 - 07/2021
3	pretomanidIBA 11/2023 - 04/2015
3	Meropenem (Merrem)FDA LinkGeneric 10/2023 - 01/2016
3	Pyrazinamide FDA LinkGeneric 07/2023 - 03/2015
3	Interferon-gamma (Interferon, gamma)IBA 02/2023 - 08/2003
3	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2005
3	Methacholine Chloride (Methacholine)FDA Link 12/2019 - 08/2003
3	InterleukinsIBA 01/2015 - 07/2010
2	Tumor Necrosis Factor InhibitorsIBA 04/2024 - 01/2014
2	rifapentine (Priftin)FDA Link 07/2023 - 01/2022
2	Genetic Markers (Genetic Marker)IBA 02/2023 - 08/2002
2	OPC-67683IBA 01/2023 - 04/2015
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2023 - 01/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2020 - 07/2007
2	Clofazimine (Lamprene)FDA Link 01/2019 - 01/2018
2	Nucleic AcidsIBA 01/2018 - 10/2009
2	GlucocorticoidsIBA 06/2017 - 09/2011
2	LactamsIBA 07/2016 - 03/2014
2	Apolipoproteins E (ApoE)IBA 10/2014 - 11/2008
2	SmokeIBA 04/2013 - 12/2009
2	nasIBA 02/2012 - 12/2009
2	Antiviral Agents (Antivirals)IBA 08/2004 - 01/2003
1	Janus Kinase InhibitorsIBA 04/2024
1	Janus KinasesIBA 04/2024
1	Activins (Activin)IBA 02/2024
1	activin AIBA 02/2024
1	AngiotensinsIBA 02/2024
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 02/2024
1	Drug CombinationsIBA 11/2023
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 10/2023
1	Ertapenem (Invanz)FDA Link 10/2023
1	Moxifloxacin (Avelox)FDA Link 07/2023
1	HLA-DM antigens (HLA-DMA)IBA 01/2023
1	S100A12 ProteinIBA 01/2023

Therapy/Procedure

31	Therapeutics 02/2024 - 09/2007
10	Drug Therapy (Chemotherapy) 07/2021 - 07/2010
6	Duration of Therapy 02/2024 - 08/2014
6	Precision Medicine 11/2022 - 01/2016
3	Art Therapy 11/2021 - 01/2018
3	Mechanical Ventilators (Ventilator) 01/2021 - 10/2017
3	Injections 01/2021 - 03/2015
2	Noninvasive Ventilation 01/2021 - 01/2020
2	Immunotherapy 12/2019 - 10/2015